Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Amlodipine 2.5 mg
Total 0 results
Nothing found
Sponsors and Collaborators
Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
Sahachat Aueyingsak
Åke Wibergs Stiftelse
ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
Daniela Pacella - University of Naples Federico II, Naples
Sublimity Therapeutics Holdco Limited
the people hospital of Linzhi
Glasgow Western Infirmary
National Institute of Cardiovascular Diseases, Bangladesh
The Australia-Israel Scientific Exchange Foundation (AISEF)
Hospitales Universitarios Virgen del Rocío
Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
Dr Philippe METELLUS
IRCCS Istituto Auxologico Italiano, Milano, Italy
Etan Orgel
AlpinARC
ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
ECMC
Bassam Abdulkarim
Centro Universitário Franciscano
View Full List
Medical Conditions
Initiation of Depo-Provera (DMPA)
Interviews
Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
Progression to PD-1 Antibody
Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
Orthopaedic Disorders
Bladder Cancer TNM Staging Primary Tumor (T) T2B
Legal History
Adult Patients Undergoing Surgery That Requires General Anesthesia
Degenerative Spondylolisthesis G1
Ability to Swim 100m Independent Freestyle
Patients With Leptomeningeal Disease
Panniculectomy
Eosinophil Blood Count
Genetic Risk Factor
Value-Based Health Insurance
Transitional Cell Carcinoma of Renal Pelvis
Very Long Chain Acyl Coa Dehydrogenase Deficiency
Hyperprolinemia
Pancreaticoduodenectomy
View Full List
Drug Interventions
Nimotuzumab
ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
Prasugrel
6% hetastarch
Mepivacaine
HBM4003 and Triprilimab
Cefuroxime 750mg oral
0% N2O
Paliperidone palmitate
UFUR and Iressa
Gefitinib
Metoclopramide + dexamethasone
Antibiotic treatment
Omeprazole 20mg
5-Fluoro-uracil
Erythropoietin
Injectable Insulin
ASP8062
IV rtPA (intravenous recombinant plasminogen activator)
Epirubicin hydrochloride
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Algeria
Contract Research Organizations in Angola
Contract Research Organizations in Argentina
Contract Research Organizations in El Salvador
Contract Research Organizations in Japan
Contract Research Organizations in Kosovo
Contract Research Organizations in Lebanon
Contract Research Organizations in Luxembourg
Contract Research Organizations in Malawi
Contract Research Organizations in Norway
Contract Research Organizations in Singapore
Contract Research Organizations in Thailand
CRO list by country
CROs in Togo
SGS
All CROs in Togo
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe